Fenofibrate 60219-5522
Product NDC
60219-5522- Manufacturer
- Amneal Pharmaceuticals Ny Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 22, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA076509
Need to source Fenofibrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fenofibrate | 160 mg/1 |
Drug Class
Peroxisome Proliferator Receptor alpha Agonist [EPC]Peroxisome Proliferator Receptor alpha Agonist [EPC]
Packaging Options(2)
500 TABLET in 1 BOTTLE (60219-5522-5)
90 TABLET in 1 BOTTLE (60219-5522-9)